menu
    • menu

    Company profile for IncellDx

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    IncellDx, Inc. is a single cell diagnostic company committed to advancing Precision Medicine by offering transformative diagnostic and prognostic clinical patient information based on an innovative technology platform that enables simultaneous cell classification and single cell analysis of proteomic and genomic biomarkers. IncellDx technology combines a unique multiplex RNA in situ hybridization method called Simultaneous Ult...
    IncellDx, Inc. is a single cell diagnostic company committed to advancing Precision Medicine by offering transformative diagnostic and prognostic clinical patient information based on an innovative technology platform that enables simultaneous cell classification and single cell analysis of proteomic and genomic biomarkers. IncellDx technology combines a unique multiplex RNA in situ hybridization method called Simultaneous Ultrasensitive Signal-amplified Hybridization In Situ (SUSHI) with a novel, cell-based instrument capable of quantifying multiple proteins and molecular biomarkers inside intact cells.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    IncellDxUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    1541 Industrial Road, San Carlos, CA 94070
    Telephone
    Telephone
    1.650.777.7630
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://incelldx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/incelldx
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    IncellDx Awarded Patent for Use of CCR5 Antagonist Maraviroc
    IncellDx Awarded Patent for Use of CCR5 Antagonist Maraviroc

    23 Nov 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20211123005960/en

    BUSINESSWIRE
    23 Nov 2021
    Share Share
    IncellDx’s CCTC Partners with ARISE MD Integrative Medicine & Surgery
    IncellDx’s CCTC Partners with ARISE MD Integrative Medicine & Surgery

    18 Nov 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20211118006240/en

    BUSINESSWIRE
    18 Nov 2021
    Share Share
    IncellDx to Study Maraviroc, a CCR5 antagonist, in a COVID-19 Ph2 Clinical Trial
    IncellDx to Study Maraviroc, a CCR5 antagonist, in a COVID-19 Ph2 Clinical Trial

    20 Oct 2020

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/incelldx-to-study-maraviroc-a-ccr5-antagonist-in-a-covid-19-phase-2-clinical-trial-301155514.html

    PRNEWSWIRE
    20 Oct 2020
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search